Skip to main content
NCBI home page
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
editorial
. 2007 Mar;22(1):1–3. doi: 10.1007/BF02912872

Metabolic syndrome: Early identification prevents type II diabetes and cardiovascular disease

Praveen Sharma 1,✉, Sandhya Mishra 1
PMCID: PMC3454255  PMID: 23105643

Full Text

The Full Text of this article is available as a PDF (57.5 KB).

References

  • 1.Reaven GM. Role of Insulin Resistance in Human Disease. Diabetes. 1988;37:1595–1607. doi: 10.2337/diab.37.12.1595. [DOI] [PubMed] [Google Scholar]
  • 2.Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Geneva: WHO Department of Noncommunicable Disease Surveillance; 1999. [Google Scholar]
  • 3.Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). J. Am. Med. Assoc. 2001; 285: 2486–97. [DOI] [PubMed]
  • 4.International Diabetes Federation. New IDF worldwide definition of the metabolic syndrome. Press conference, Ist International congress on Pre-diabetes” and the metabolic syndrome. Berlin, Germany. April 14, 2005 (www.idf.org).
  • 5.Enas A Enas @ http://www.cadiresearch.com/ publications.htm
  • 6.Mckeigue PM, Shah B, Marmott MG. Relationship of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet. 1991;337:382–6. doi: 10.1016/0140-6736(91)91164-p. [DOI] [PubMed] [Google Scholar]
  • 7.Banerji MA, Faridi N, Atluri R, Chaiken RL, Lebovitz HE. Body composition, visceralfat, leption and insulin resistance in Asian Indian men. J. Clin Endocrinol Metab. 1999;84:137–44. doi: 10.1210/jcem.84.1.5371. [DOI] [PubMed] [Google Scholar]
  • 8.Enas EA, Yusuf S, Mehta JL. Prevalence of coronary artery disease in Asian Indians. Am J Cardiol. 1992;70:945–9. doi: 10.1016/0002-9149(92)90744-j. [DOI] [PubMed] [Google Scholar]
  • 9.Chandalia M, Abate N, Garg A, Stray-Gundersen J, Grundy SM. Relationship between generalized and upper body obesity to insulin resistance in Asian Indian men. J Clin Endocrinol Metab. 1999;84:2329–35. doi: 10.1210/jcem.84.7.5817. [DOI] [PubMed] [Google Scholar]
  • 10.WHO recommendations: Obesity: Preventing and Managing the Global Epidemic. Geneva: World Health Org; 2000. [PubMed] [Google Scholar]
  • 11.Wilson PWF, Kannel WB, Silbershatz H, D'Agostino RB. Clustering of metabolic factors and coronary heart disease. Arch Intern Med. 1999;159:1104–9. doi: 10.1001/archinte.159.10.1104. [DOI] [PubMed] [Google Scholar]
  • 12.Golden SH, Folsom AR, Coresh J, Sharrett AR, Szklo M, Brancati F. Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities study. Diabetes. 2002;51:3069–76. doi: 10.2337/diabetes.51.10.3069. [DOI] [PubMed] [Google Scholar]
  • 13.Girman CJ, Rhodes T, Clearfield M, Beere PA, Mercuri M. Metabolic syndrome and risk of cardiovascular outcome in the placebo groups of two large clinical trials. http:// aha.agora.com/abstractiviewer/results.asp
  • 14.Domanski M, Proschan M, Maryland B. The Metabolic Syndrome. JACC. 2004;43(8):1396–8. doi: 10.1016/j.jacc.2004.01.021. [DOI] [PubMed] [Google Scholar]
  • 15.Sharma P, Mishra S, Ajmera P, Mathur S. Oxidative Stress in metabolic syndrome. Indian J Clin Biochem. 2005;20(1):150–4. doi: 10.1007/BF02893061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kcriakas D, Willerson J. Metabolic syndrome epidemic. Circulation. 2006;108:1552–3. doi: 10.1161/01.CIR.0000093203.00632.2B. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES